Table 1 The correlation of AVL9 expression with clinicopathological features of colorectal carcinoma patients
From: AVL9 promotes colorectal carcinoma cell migration via regulating EGFR expression
| Â | Number of cases | Negative, weak | Moderate, strong | P value |
|---|---|---|---|---|
| Â | (n = 83) | (n = 50) | (n = 33) | Â |
Age (years) | ||||
 > 50 | 60 | 33 | 27 | 0.115 |
 ≤ 50 | 23 | 17 | 6 |  |
Gender | ||||
 Male | 50 | 27 | 23 | 0.152 |
 Female | 33 | 23 | 10 |  |
Tumor size | ||||
 ≤ 5 cm | 50 | 28 | 22 | 0.331 |
 > 5 cm | 33 | 22 | 11 |  |
T classification | ||||
 T1, T2 | 17 | 12 | 5 | 0.328 |
 T3, T4 | 66 | 38 | 28 |  |
N status | ||||
 N0 | 52 | 29 | 23 | 0.281 |
 N1-3 | 31 | 21 | 10 |  |
Metastasis | ||||
 M0 | 35 | 14 | 21 | 0.001 |
 M1 | 48 | 36 | 12 |  |
Stage | ||||
 I, II | 32 | 15 | 17 | 0.048 |
 III, IV | 51 | 35 | 16 |  |